0.5769
-0.0414
(-6.70%)
At close: 4:00:02 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.22 | -0.15 | -1.2 | -0.5 |
| Low Estimate | -0.22 | -0.15 | -1.2 | -0.5 |
| High Estimate | -0.22 | -0.15 | -1.2 | -0.5 |
| Year Ago EPS | -0.26 | -0.38 | -1.62 | -1.2 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 1 | 2 |
| Avg. Estimate | 2.84M | 5M | 11M | 19.99M |
| Low Estimate | 2.68M | 5M | 11M | 15.97M |
| High Estimate | 3M | 5M | 11M | 24M |
| Year Ago Sales | 2.13M | 2.15M | 9.15M | 11M |
| Sales Growth (year/est) | 33.37% | 132.23% | 20.17% | 81.70% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.32 | -0.33 | -0.28 |
| EPS Actual | -0.26 | -0.38 | -0.32 | -0.24 |
| Difference | 0.15 | -0.06 | 0.01 | 0.04 |
| Surprise % | 36.83% | -19.19% | 1.79% | 13.74% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.22 | -0.15 | -1.2 | -0.5 |
| 7 Days Ago | -0.22 | -0.15 | -1.2 | -0.5 |
| 30 Days Ago | -0.28 | -0.16 | -1.2 | -0.5 |
| 60 Days Ago | -0.28 | -0.16 | -1.2 | -0.5 |
| 90 Days Ago | -0.28 | -0.16 | -1.2 | -0.5 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AWH | 15.06% | 60.67% | 25.97% | 58.33% |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Maintains | Alliance Global Partners: Buy to Buy | 8/14/2024 |
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 4/10/2024 |
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 4/1/2024 |
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 9/26/2023 |
| Initiated | Alliance Global Partners: Buy | 8/22/2023 |
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 5/17/2023 |
Related Tickers
IDXG Interpace Biosciences, Inc.
1.0000
+78.38%
EDTXF Spectral Medical Inc.
0.3730
0.00%
PRE Prenetics Global Limited
5.81
+0.43%
MYGN Myriad Genetics, Inc.
13.68
-4.20%
SONA.CN Sona Nanotech Inc.
0.2700
+5.88%
BDSX Biodesix, Inc.
1.1300
-8.87%
CDNA CareDx, Inc
22.05
-12.05%
PRPH ProPhase Labs, Inc.
0.6055
-5.39%
ACRS Aclaris Therapeutics, Inc.
2.5000
+0.81%
BIAF bioAffinity Technologies, Inc.
0.7575
+0.37%